Research Article
Assessment of Hepatitis C virus (HCV) associated with hemodialysis patients in Thi-Qar province, Iraq
@INPROCEEDINGS{10.4108/eai.7-9-2021.2315370, author={Ali Abdulhussein Khalaf and Khwam R Hussein}, title={Assessment of Hepatitis C virus (HCV) associated with hemodialysis patients in Thi-Qar province, Iraq}, proceedings={Proceedings of 2nd International Multi-Disciplinary Conference Theme: Integrated Sciences and Technologies, IMDC-IST 2021, 7-9 September 2021, Sakarya, Turkey}, publisher={EAI}, proceedings_a={IMDC-IST}, year={2022}, month={1}, keywords={hcv hemodialysis patients pcr ns5b and 5'utr}, doi={10.4108/eai.7-9-2021.2315370} }- Ali Abdulhussein Khalaf
Khwam R Hussein
Year: 2022
Assessment of Hepatitis C virus (HCV) associated with hemodialysis patients in Thi-Qar province, Iraq
IMDC-IST
EAI
DOI: 10.4108/eai.7-9-2021.2315370
Abstract
Hepatitis is liver inflammation that can lead to many fatal health problems. Hepatitis C virus (HCV) is a blood-borne virus. Hemodialysis patients are at greater risk of acquiring HCV infection and this is a major global health problem. The study included 120 samples from patients who underwent dialysis at the age range of 20 to 87 years; males were 58.3% while 41.7% were females. The study confirmed that the percentage of HCV infection among Hemodialysis patients was 30%, the high rate was in age groups 50-59 years (33.3 %), in males is high than females. There was an association between blood transfusion and HCV infection (P value=0.037). Also, the high percentage was in patients who remained more than 36 months 50.0% and twice sessions per week at 61.1%. Six isolates were recorded in the global GenBank with accession numbers: MW947494- MW947499. History of blood transfusions and a long period of Hemodialysis treatment were major risk factors for anti-HCV positive. HCV RNA testing should be conducted on all patients prior to Hemodialysis and blood before transfusion using PCR.
